BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32016808)

  • 1. Metastatic Anaplastic Thyroid Carcinoma in Complete Remission: Morphological, Molecular, and Clinical Work-Up of a Rare Case.
    Stenman A; Hellgren LS; Jatta K; Hysek M; Zemmler M; Altena R; Nilsson IL; Bränström R; Zedenius J; Juhlin CC
    Endocr Pathol; 2020 Mar; 31(1):77-83. PubMed ID: 32016808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Pathology of Anaplastic Thyroid Carcinomas: A Retrospective Study of 144 Cases.
    Bonhomme B; Godbert Y; Perot G; Al Ghuzlan A; Bardet S; Belleannée G; Crinière L; Do Cao C; Fouilloux G; Guyetant S; Kelly A; Leboulleux S; Buffet C; Leteurtre E; Michels JJ; Tissier F; Toubert ME; Wassef M; Pinard C; Hostein I; Soubeyran I
    Thyroid; 2017 May; 27(5):682-692. PubMed ID: 28351340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in
    Wang JR; Zafereo ME; Dadu R; Ferrarotto R; Busaidy NL; Lu C; Ahmed S; Gule-Monroe MK; Williams MD; Sturgis EM; Goepfert RP; Gross ND; Lai SY; Gunn GB; Phan J; Rosenthal DI; Fuller CD; Morrison WH; Iyer P; Cabanillas ME
    Thyroid; 2019 Aug; 29(8):1036-1043. PubMed ID: 31319771
    [No Abstract]   [Full Text] [Related]  

  • 4. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
    Xu B; Fuchs T; Dogan S; Landa I; Katabi N; Fagin JA; Tuttle RM; Sherman E; Gill AJ; Ghossein R
    Thyroid; 2020 Oct; 30(10):1505-1517. PubMed ID: 32284020
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaplastic thyroid carcinoma with rhabdoid phenotype: An unusual case and a comprehensive review.
    Bansal S; Sancheti S; Kaur S; Somal P; Kalra SK; Sali AP
    Diagn Cytopathol; 2020 Nov; 48(11):1125-1130. PubMed ID: 32515545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
    Molinaro E; Romei C; Biagini A; Sabini E; Agate L; Mazzeo S; Materazzi G; Sellari-Franceschini S; Ribechini A; Torregrossa L; Basolo F; Vitti P; Elisei R
    Nat Rev Endocrinol; 2017 Nov; 13(11):644-660. PubMed ID: 28707679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.
    Wong KS; Lorch JH; Alexander EK; Nehs MA; Nowak JA; Hornick JL; Barletta JA
    Thyroid; 2019 May; 29(5):666-673. PubMed ID: 30869569
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical Utility of Circulating Cell-Free DNA Mutations in Anaplastic Thyroid Carcinoma.
    Qin Y; Wang JR; Wang Y; Iyer P; Cote GJ; Busaidy NL; Dadu R; Zafereo M; Williams MD; Ferrarotto R; Gunn GB; Wei P; Patel K; Hofmann MC; Cabanillas ME
    Thyroid; 2021 Aug; 31(8):1235-1243. PubMed ID: 33599171
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary squamous cell carcinoma of thyroid with a novel BRAF mutation and High PDL-1 expression: A case report with treatment implications and review of literature.
    Torrez M; Braunberger RC; Yilmaz E; Agarwal S
    Pathol Res Pract; 2020 Oct; 216(10):153146. PubMed ID: 32853962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma.
    Sandulache VC; Williams MD; Lai SY; Lu C; William WN; Busaidy NL; Cote GJ; Singh RR; Luthra R; Cabanillas ME
    Thyroid; 2017 Jan; 27(1):81-87. PubMed ID: 27785980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
    Shi X; Liu R; Qu S; Zhu G; Bishop J; Liu X; Sun H; Shan Z; Wang E; Luo Y; Yang X; Zhao J; Du J; El-Naggar AK; Teng W; Xing M
    J Clin Endocrinol Metab; 2015 Apr; 100(4):E632-7. PubMed ID: 25584719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
    Stenman A; Hysek M; Jatta K; Bränström R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
    Endocr Pathol; 2019 Sep; 30(3):246-248. PubMed ID: 31154561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma.
    Nachalon Y; Stern-Shavit S; Bachar G; Shvero J; Limon D; Popovtzer A
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1128-32. PubMed ID: 26512447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clear Cell Variant of Papillary Thyroid Carcinoma With Associated Anaplastic Thyroid Carcinoma: Description of an Extraordinary Case.
    Juhlin CC; Höög A
    Int J Surg Pathol; 2019 Sep; 27(6):658-663. PubMed ID: 30931661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology.
    Pinto AT; Pojo M; Simões-Pereira J; Roque R; Saramago A; Roque L; Martins C; André S; Cabeçadas J; Leite V; Cavaco BM
    Endocrine; 2019 Nov; 66(2):288-300. PubMed ID: 31368081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive anaplastic thyroid carcinoma: report of a case and literature review.
    Dibelius G; Mehra S; Clain JB; Urken ML; Wenig BM
    Thyroid; 2014 Aug; 24(8):1319-24. PubMed ID: 24865498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of Clinicopathologic Characteristics and Survival Outcomes of Anaplastic and Poorly Differentiated Thyroid Carcinoma.
    Lee DY; Won JK; Lee SH; Park DJ; Jung KC; Sung MW; Wu HG; Kim KH; Park YJ; Hah JH
    Thyroid; 2016 Mar; 26(3):404-13. PubMed ID: 26541309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.